 I'm Chad Robinson with your Money Now. Blockbuster weight loss drugs such as Wagovi and Ozempic may be associated with a rare eye condition, according to a new study released Wednesday. A Novo Nordisk spokesperson says there were key methodical limitations to that study, one analyst describing the results as hardly a game changer, adding that a worst-case scenario would likely result in a further update to the drug's label.